Augmentation of the antimicrobial efficacy of antibiotics by filamentous phage

Microbial Drug Resistance

Volumn 12, Issue 3, 2006, Pages 164-168

  Hagens, Steven ^a,b   Habel, André ^c   Bläsi, Udo ^a  

^a Vienna Biocenter   (Austria)

^b ETH ZURICH   (Switzerland)

^c INTERCELL AG   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBENICILLIN; CHLORAMPHENICOL; GENTAMICIN; TETRACYCLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIOPHAGE PF3; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GRAM NEGATIVE INFECTION; IN VITRO STUDY; LETHALITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIOPHAGE PF1; GENTAMICINS; INOVIRUS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSEUDOMONAS PHAGES;

PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PHAGE PF1; PSEUDOMONAS PHAGE PF3;

EID: 33751234484     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.164     Document Type: Article

References (17)

1. Hagens, S., A. Habel, U. von Ahsen, A. von Gabain, and U. Bläsi. 2004. Therapy of experimental Pseudomonas infections with a nonreplicating genetically modified phage. Antimicrob. Agents Chemother. 48:3817-3822.
2. Marciano, D.K., M. Russel, and S.M. Simon. 1999. An aqueous channel for filamentous phage export. Science 284:1516-1519.
3. Marciano, D.K., M. Russel, and S.M. Simon. 2001. Assembling filamentous phage occlude pIV channels. Proc. Natl. Acad. Sci. USA 98:9359-9364.
4. Opalka, N., R. Beckmann, N. Boisset, M.N. Simon, M. Russel, and S.A. Darst. 2003. Structure of the filamentous phage pIV multimer by cryo-electron microscopy. J. Mol. Biol. 325:461-470.
5. Merril, C.R., D. Scholl, and S.L. Adhya. 2003. The prospect for bacteriophage therapy in Western medicine. Nature Rev. Drug Discov. 2:489-497.
6. Pansegrau, W., E. Lanka, P.T. Barth, D.H. Figurski, D.G. Guiney, D. Haas, D.R. Helinski, H. Schwab, V. Stanisich, and C.M. Thomas. 1994. Complete nucleotide sequence of Birmingham IncPα plasmids. J. Mol. Biol. 239:623-663.
7. Paya, C.V., and P.E. Hermans. 1989. Bacterial infections after liver transplantation. Europ. J. Clin. Microbiol. Infec. Dis. 6:499-504.
8. Riffenburgh, R.H. 1999. Statistics in medicine. Academic Press, Inc., New York.
9. Rolinson, G.N. 1988. Evolution of beta-lactamase inhibitors J. Reprod. Med. 33:571-573.
10. Russel, M. 1995. Moving through the membrane with filamentous phage. Trends Microbiol. 3:223-228.
11. nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
12. Stanisich, V.A. 1974. The properties and host range of specific bacteriophage of Pseudomonas aeruginosa. J. Gen. Microbiol. 84:332-342.
13. Sulakvelidze, A., Z. Alavidze, and J.G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649-659.
14. Wersall, J., P.G. Lundquist, and B. Bjorkroth. 1969. Ototoxicity of gentamicin. J. Infect. Dis. 119:410-416.
15. West, S.E.H., H.P. Schweizer, C. Dali, A.K. Sample, and L.J. Runyen-Janecky. 1994. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148:81-86.
16. Yagel, S., J.F. Barrett, D.J. Amaratunga, and M.B. Frosco. 1996. In vivo oral efficiacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia. Antimicrob. Agents Chemother. 40:2894-2897.
17. Xian-Zhi, L., L. Zhang, and K. Poole. 2000. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45:433-436.